Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

[Antibiotic prophylaxis in intestinal surgery – renaissance for a classical combination?].

Burman LG.

Lakartidningen. 2017 Nov 14;114. pii: EWEP. Swedish. No abstract available.

2.

[Lipid A - possible effective prophylaxis? Epigenetics may lose its importance in allergy].

Burman LG.

Lakartidningen. 2016 May 16;113. pii: D3AZ. Swedish. No abstract available.

3.

Analysis of rRNA processing and translation in mammalian cells using a synthetic 18S rRNA expression system.

Burman LG, Mauro VP.

Nucleic Acids Res. 2012 Sep;40(16):8085-98. doi: 10.1093/nar/gks530. Epub 2012 Jun 20.

4.

In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.

Norén T, Alriksson I, Akerlund T, Burman LG, Unemo M.

Clin Microbiol Infect. 2010 Aug;16(8):1104-10. doi: 10.1111/j.1469-0691.2009.03048.x. Epub 2009 Sep 3.

5.

Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism.

Karlsson S, Burman LG, Akerlund T.

Microbiology. 2008 Nov;154(Pt 11):3430-6. doi: 10.1099/mic.0.2008/019778-0.

PMID:
18957596
6.

Alcohol-based hand-disinfection reduced children's absence from Swedish day care centers.

Lennell A, Kühlmann-Berenzon S, Geli P, Hedin K, Petersson C, Cars O, Mannerquist K, Burman LG, Fredlund H; Study Group.

Acta Paediatr. 2008 Dec;97(12):1672-80. doi: 10.1111/j.1651-2227.2008.01057.x. Epub 2008 Oct 1.

PMID:
18945282
7.

Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.

Burman LG.

Am J Gastroenterol. 2008 Aug;103(8):2147; author reply 2147. doi: 10.1111/j.1572-0241.2008.01982_7.x. No abstract available.

PMID:
18796117
8.

Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemics.

Johansen K, Mannerqvist K, Allard A, Andersson Y, Burman LG, Dillner L, Hedlund KO, Jönsson K, Kumlin U, Leitner T, Lysén M, Thorhagen M, Tiveljung-Lindell A, Wahlström C, Zweygberg-Wirgart B, Widell A.

J Clin Virol. 2008 Jun;42(2):129-34. doi: 10.1016/j.jcv.2007.12.012. Epub 2008 Mar 4.

PMID:
18304864
9.

Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.

Akerlund T, Persson I, Unemo M, Norén T, Svenungsson B, Wullt M, Burman LG.

J Clin Microbiol. 2008 Apr;46(4):1530-3. doi: 10.1128/JCM.01964-07. Epub 2008 Feb 20.

10.

[Antibiotic resistant S aureus--increased mortality and more expensive health care].

Melander E, Burman LG, Cars O.

Lakartidningen. 2007 Oct 17-23;104(42):3052-6. Review. Swedish. No abstract available.

PMID:
17985713
11.

Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.

Hanberger H, Burman LG, Cars O, Erlandsson M, Gill H, Nilsson LE, Nordlinder D, Walther SM; ICU STRAMA Study Group.

Acta Anaesthesiol Scand. 2007 Aug;51(7):937-41.

PMID:
17635399
12.

Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.

Erlandsson M, Burman LG, Cars O, Gill H, Nilsson LE, Walther SM, Hanberger H; Strama-Icu Study Group.

Scand J Infect Dis. 2007;39(1):63-9.

PMID:
17366015
13.

Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.

Norén T, Akerlund T, Wullt M, Burman LG, Unemo M.

Antimicrob Agents Chemother. 2007 May;51(5):1840-3. Epub 2007 Feb 16.

14.

Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Norén T, Wullt M, Akerlund T, Bäck E, Odenholt I, Burman LG.

Antimicrob Agents Chemother. 2006 Sep;50(9):3028-32.

15.

Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Aspevall O, Lundberg A, Burman LG, Akerlund T, Svenungsson B.

Antimicrob Agents Chemother. 2006 May;50(5):1890-2.

16.
18.

Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions.

Kühn I, Iversen A, Finn M, Greko C, Burman LG, Blanch AR, Vilanova X, Manero A, Taylor H, Caplin J, Domínguez L, Herrero IA, Moreno MA, Möllby R.

Appl Environ Microbiol. 2005 Sep;71(9):5383-90.

19.

Rectal colonization and frequency of enterococcal cross-transmission among prolonged-stay patients in two Swedish intensive care units.

Hällgren A, Burman LG, Isaksson B, Olsson-Liljeqvist B, Nilsson LE, Saeedi B, Walther S, Hanberger H.

Scand J Infect Dis. 2005;37(8):561-571.

PMID:
16138424
20.

Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Norén T, Akerlund T, Bäck E, Sjöberg L, Persson I, Alriksson I, Burman LG.

J Clin Microbiol. 2004 Aug;42(8):3635-43.

21.

Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers.

Henriqus Normark B, Christensson B, Sandgren A, Noreen B, Sylvan S, Burman LG, Olsson-Liljequist B.

Microb Drug Resist. 2003 Winter;9(4):337-44.

PMID:
15008138
22.

High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility.

Hanberger H, Erlandsson M, Burman LG, Cars O, Gill H, Lindgren S, Nilsson LE, Olsson-Liljequist B, Walther S; ICU-STRAMA Study Group.

Scand J Infect Dis. 2004;36(1):24-30.

PMID:
15000555
23.

Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium.

Iversen A, Kühn I, Rahman M, Franklin A, Burman LG, Olsson-Liljequist B, Torell E, Möllby R.

Environ Microbiol. 2004 Jan;6(1):55-9.

PMID:
14686941
24.

Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance.

Torell E, Kühn I, Olsson-Liljequist B, Haeggman S, Hoffman BM, Lindahl C, Burman LG.

Clin Microbiol Infect. 2003 Oct;9(10):1011-9.

25.

Comparison of enterococcal populations in animals, humans, and the environment--a European study.

Kühn I, Iversen A, Burman LG, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth AM, Blanch AR, Vilanova X, Taylor H, Caplin J, Moreno MA, Dominguez L, Herrero IA, Möllby R.

Int J Food Microbiol. 2003 Dec 1;88(2-3):133-45.

PMID:
14596986
26.

Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile.

Wullt M, Burman LG, Laurell MH, Akerlund T.

J Hosp Infect. 2003 Oct;55(2):124-30.

PMID:
14529637
27.
28.

Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature.

Karlsson S, Dupuy B, Mukherjee K, Norin E, Burman LG, Akerlund T.

Infect Immun. 2003 Apr;71(4):1784-93.

29.

Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.

Lidman C, Burman LG, Lagergren A, Ortqvist A.

Scand J Infect Dis. 2002;34(12):873-9.

PMID:
12587618
30.

Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units.

Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksson B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H; Icustrama Study Group.

Acta Anaesthesiol Scand. 2002 Oct;46(9):1075-81.

PMID:
12366501
31.

Proteins released during high toxin production in Clostridium difficile.

Mukherjee K, Karlsson S, Burman LG, Akerlund T.

Microbiology. 2002 Jul;148(Pt 7):2245-53.

PMID:
12101311
34.
35.

Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis.

Khalil A, Tullus K, Bakhiet M, Burman LG, Jaremko G, Brauner A.

J Urol. 2000 Jul;164(1):186-91.

PMID:
10840457
36.

Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme.

Kühn I, Iversen A, Burman LG, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth AM, Blanch AR, Taylor H, Caplin J, Moreno MA, Dominguez L, Möllby R.

Int J Antimicrob Agents. 2000 May;14(4):337-42.

PMID:
10794956
37.
38.

[Uncomplicated lower urinary tract infection: 3-day therapy is recommended!].

Mölstad S, Burman LG, Ferry S.

Lakartidningen. 1999 Sep 29;96(39):4212-4. Swedish. No abstract available.

PMID:
10544588
39.
41.

Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids.

Karlsson S, Burman LG, Akerlund T.

Microbiology. 1999 Jul;145 ( Pt 7):1683-93.

PMID:
10439407
43.

Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit.

Finnström O, Isaksson B, Haeggman S, Burman LG.

Acta Paediatr. 1998 Oct;87(10):1070-4.

PMID:
9825975
44.
45.

A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group.

Karlström O, Fryklund B, Tullus K, Burman LG.

Clin Infect Dis. 1998 Jan;26(1):141-5.

PMID:
9455523
46.
47.

Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice.

Khalil A, Brauner A, Bakhiet M, Burman LG, Jaremko G, Wretlind B, Tullus K.

J Urol. 1997 Oct;158(4):1576-80.

PMID:
9302176
48.

[Epidemic C difficile-associated diarrhea is a reality. Fewer prescriptions and more soap].

Karlström O, Fryklund B, Tullus K, Burman LG.

Lakartidningen. 1997 Jun 4;94(23):2187-92. Swedish. No abstract available.

PMID:
9213685
49.
50.

Zoned vertical ultraclean operating room ventilation. A novel concept making long side walls unnecessary.

Friberg BE, Friberg S, Burman LG.

Acta Orthop Scand. 1996 Dec;67(6):578-82.

PMID:
9065071

Supplemental Content

Loading ...
Support Center